Proteins
Research Areas
Products Related to Proteins(726)
- GC64039Disitamab vedotinCAS: 2136633-23-1Purity: >97.00%
Disitamab vedotin is an antibody-drug conjugate (ADC) targeting HER2 protein that is comprised of hertuzumab coupling monomethyl auristatin E (MMAE) via a cleavable linker.
- GC64161Calcium glycerophosphateCAS: 27214-00-2Purity: >98.00%
Calcium glycerophosphate is an inhibitor of intestinal alkaline phosphatase F3.
- GC64556PTP1B-IN-15CAS: 765317-71-3Purity: >98.00%
PTP1B-IN-15 is a potent and selective inhibitor of protein tyrosine phosphatase 1B (PTP1B).
- GC64605MY33-3 hydrochlorideCAS: 2204280-42-0Purity: >99.00%
MY33-3 hydrochloride is a potent and selective inhibitor of receptor protein tyrosine phosphatase (RPTP)β/ζ, with an IC50 of ~0.1 μM.
- GC64930Sacituzumab govitecanCAS: 1491917-83-9Purity: >98.00%
Sacituzumab govitecan (IMMU-132) is an antibody-drug conjugate (ADC) targeting Trop-2 for delivery of SN-38. Sacituzumab govitecan shows anticancer activity.
- GC64936TD52 dihydrochloridePurity: >98.00%
TD52 dihydrochloride, an Erlotinib derivative, is an orally active, potent cancerous inhibitor of protein phosphatase 2A (CIP2A) inhibitor. TD52 dihydrochloride mediates the apoptotic effect in triple-negative breast cancer (TNBC) cells via regulating the CIP2A/PP2A/p-Akt signalling pathway. TD52 dihydrochloride indirectly reduced CIP2A by disturbing Elk1 binding to the CIP2A promoter. TD52 dihydrochloride has less p-EGFR inhibition and has potent anti-cancer activity.
- GC64948CD38 inhibitor 1CAS: 1700637-55-3Purity: >99.00%
CD38 inhibitor 1 is a potent CD38 inhibitor with an IC 50 value of 1.9nM for mouse CD38.
- GC65025BCI hydrochlorideCAS: 95130-23-7Purity: >99.00%
BCI ((E)-BCI) hydrochloride is a DUSP6 (dual specificity phosphatase 6) inhibitor.
- GC65097ARL67156 trisodium hydratePurity: >99.00%
ARL67156 (FPL 67156) trisodium hydrate is a selective ecto-ATPase inhibitor.
- GC65098ARL67156 triethylaminePurity: >99.50%
ARL67156 (FPL 67156) triethylamine is a selective ecto-ATPase inhibitor.
- GC65157Naphthol AS-BRCAS: 91-92-9Purity: >98.00%
Naphthol AS-BR is a substrate for the histochemical demonstration of acid and alkaline phosphatase.
- GC65308SHIP2-IN-1CAS: 2252247-80-4Purity: >99.00%
SHIP2-IN-1 is a potent SHIP2 inhibitor, inhibits SHIP2 activity, with an IC50 of 2 ?M.
- GC65542NSC-87877 disodiumCAS: 56932-43-5Purity: >98.00%
NSC-87877 disodium is a potent inhibitor of Shp2 and Shp1 protein tyrosine phosphatases (SH-PTP2 and SH-PTP1), with IC50 values of 0.318 μM, 0.355 μM shp2 and shp1, respectively. NSC-87877 also inhibits dual-specificity phosphatase 26 (DUSP26).
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC64039 | Disitamab vedotin | 2136633-23-1 | >97.00% | |
Disitamab vedotin is an antibody-drug conjugate (ADC) targeting HER2 protein that is comprised of hertuzumab coupling monomethyl auristatin E (MMAE) via a cleavable linker. | ||||
| GC64119 | Saponarin | 20310-89-8 | >98.00% | |
Saponarin is a natural flavonoid isolated from Gypsophila trichotoma, with antioxidant, anti-inflammatory and hepatoprotective activities. | ||||
| GC64161 | Calcium glycerophosphate | 27214-00-2 | >98.00% | |
Calcium glycerophosphate is an inhibitor of intestinal alkaline phosphatase F3. | ||||
| GC64338 | LYP-IN-1 | 1404436-51-6 | >98.50% | |
LYP-IN-1 is a potent, selective and specific LYP inhibitor with a Ki and an IC50 of 110 nM and 0.259 μM, respectively. | ||||
| GC64376 | GDC-1971 | 2377352-49-1 | >98.00% | |
GDC-1971 (compound 199) is a SHP2 inhibitor. | ||||
| GC64556 | PTP1B-IN-15 | 765317-71-3 | >98.00% | |
PTP1B-IN-15 is a potent and selective inhibitor of protein tyrosine phosphatase 1B (PTP1B). | ||||
| GC64605 | MY33-3 hydrochloride | 2204280-42-0 | >99.00% | |
MY33-3 hydrochloride is a potent and selective inhibitor of receptor protein tyrosine phosphatase (RPTP)β/ζ, with an IC50 of ~0.1 μM. | ||||
| GC64930 | Sacituzumab govitecan | 1491917-83-9 | >98.00% | |
Sacituzumab govitecan (IMMU-132) is an antibody-drug conjugate (ADC) targeting Trop-2 for delivery of SN-38. Sacituzumab govitecan shows anticancer activity. | ||||
| GC64936 | TD52 dihydrochloride | - | >98.00% | |
TD52 dihydrochloride, an Erlotinib derivative, is an orally active, potent cancerous inhibitor of protein phosphatase 2A (CIP2A) inhibitor. TD52 dihydrochloride mediates the apoptotic effect in triple-negative breast cancer (TNBC) cells via regulating the CIP2A/PP2A/p-Akt signalling pathway. TD52 dihydrochloride indirectly reduced CIP2A by disturbing Elk1 binding to the CIP2A promoter. TD52 dihydrochloride has less p-EGFR inhibition and has potent anti-cancer activity. | ||||
| GC64948 | CD38 inhibitor 1 | 1700637-55-3 | >99.00% | |
CD38 inhibitor 1 is a potent CD38 inhibitor with an IC 50 value of 1.9nM for mouse CD38. | ||||
| GC65025 | BCI hydrochloride | 95130-23-7 | >99.00% | |
BCI ((E)-BCI) hydrochloride is a DUSP6 (dual specificity phosphatase 6) inhibitor. | ||||
| GC65097 | ARL67156 trisodium hydrate | - | >99.00% | |
ARL67156 (FPL 67156) trisodium hydrate is a selective ecto-ATPase inhibitor. | ||||
| GC65098 | ARL67156 triethylamine | - | >99.50% | |
ARL67156 (FPL 67156) triethylamine is a selective ecto-ATPase inhibitor. | ||||
| GC65157 | Naphthol AS-BR | 91-92-9 | >98.00% | |
Naphthol AS-BR is a substrate for the histochemical demonstration of acid and alkaline phosphatase. | ||||
| GC65260 | EDP-305 | 1933507-63-1 | >96.00% | |
EDP-305 is an orally active, potent and selective farnesoid X receptor (FXR) agonist, with EC50 values of 34 nM (chimeric FXR in CHO cells) and 8 nM (full-length FXR in HEK cells). | ||||
| GC65286 | INX-SM-6 | 2734878-16-9 | >98.00% | |
INX-SM-6 can be used for targeted delivery of anti-inflammatory agent. | ||||
| GC65287 | INX-SM-56 | 2734878-18-1 | >98.00% | |
INX-SM-56 is an anti-VISTA antibody drug conjugate and can be used for targeted delivery of anti-inflammatory agents. | ||||
| GC65308 | SHIP2-IN-1 | 2252247-80-4 | >99.00% | |
SHIP2-IN-1 is a potent SHIP2 inhibitor, inhibits SHIP2 activity, with an IC50 of 2 ?M. | ||||
| GC65394 | 7-BIA | 1313403-49-4 | >98.00% | |
7-BIA is a receptor-type protein tyrosine phosphatase D (PTPRD) inhibitor with an IC50 of ~1-3 μM. | ||||
| GC65533 | SHP394 | 2055757-40-7 | >99.00% | |
SHP394 is an orally active, selective and allosteric inhibitor of SHP2, with an IC50 of 23 nM. | ||||
| GC65542 | NSC-87877 disodium | 56932-43-5 | >98.00% | |
NSC-87877 disodium is a potent inhibitor of Shp2 and Shp1 protein tyrosine phosphatases (SH-PTP2 and SH-PTP1), with IC50 values of 0.318 μM, 0.355 μM shp2 and shp1, respectively. NSC-87877 also inhibits dual-specificity phosphatase 26 (DUSP26). | ||||
| GC67798 | MLS-0437605 | 862975-18-6 | >98.00% | |
| GC67938 | Guaiacin | 36531-08-5 | >98.00% | |
| GC68296 | Brentuximab vedotin | 914088-09-8 | >99.50% | |
